FLUIDIGM (DELAWARE) (FLDM) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 40 255 sessions, April 5, 2021 to April 5, 2022
- Largest daily move
- +17.6% close of May 11, 2021
- 1-year change
- -21.2% closing prices, April 5, 2021 to April 5, 2022
- 5-year change
- -23.5% closing prices, April 5, 2017 to April 5, 2022
Company Description
FLUIDIGM (DELAWARE) (NASDAQ: FLDM) is classified in the diagnostics & research industry within the Healthcare sector and carries a market capitalization of $286.4M.
FLDM has declined 21.2% over the past year. The last closing price was $3.71.
This page collects what Stock Titan holds for FLDM, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
FLUIDIGM (DELAWARE) (FLDM) closed at $3.71 on April 5, 2022. Over the past 12 months, the price has lost 21.2%.
FLDM Metrics & Rankings
Price returns through April 5, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
FLUIDIGM (DELAWARE) has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings. View all FLDM news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
FLDM Company Profile & Sector Positioning
FLUIDIGM (DELAWARE) (FLDM) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing FLDM often look at related companies in the same sector, including Exagen Inc. (XGN), MDxHealth SA (MDXH), Prenetics Global Limited (PRE), Fonar Corporation (FONR), and Burning Rock Biotech Limited American (BNR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate FLDM's relative position within its industry.